☆ 4.6 Meeting Abstract

GENE THERAPY WITH ALIPOGENE TIPARVOVEC (GLYBERA®) FOR THE PREVENTION OF LPLD INDUCED PANCREATITIS: FOLLOW-UP DATA SUGGESTS LONG-TERM CLINICAL BENEFIT

ATHEROSCLEROSIS (2014)

Journal

ATHEROSCLEROSIS

Volume 235, Issue 2, Pages E13-E13

Publisher

ELSEVIER IRELAND LTD

DOI: 10.1016/j.atherosclerosis.2014.05.007

Keywords

-

Categories

Cardiac & Cardiovascular Systems Peripheral Vascular Disease

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.